Supreme Court questions why medicine price controls cannot cover more drugs
The Supreme Court has expressed dissatisfaction with the Centre’s response to demands for broader controls on medicine prices, questioning why restrictions on trade margins should be limited to anti-cancer drugs. A bench comprising Justices Vikram Nath and Sandeep Mehta said the government’s decision to restrict trade margins on anti-cancer medicines to 30% of their maximum retail price (MRP) did not… Continue reading "Supreme Court questions why medicine price controls cannot cover more drugs"